Surveyed adults with Sjögren disease reported high physical and emotional symptom burden and widespread dissatisfaction with available treatments.

Negative expectancies about pain and aging independently predicted 10-year worsening of pain severity and interference in older adults.

Satisfaction with semaglutide is mainly driven by effective weight loss despite gastrointestinal side effects.

Maternal tobacco smoking during pregnancy is a risk factor for increased childhood blood pressure and hypertension.

Treatment with SC vs IV tocilizumab led to higher long-term remission rates in GCA-associated aortitis, though imaging and glucocorticoid-sparing outcomes were similar.

Over 45% of visits for mental health conditions are conducted by telehealth compared with 3.3% of visits for non-mental health conditions.

Infants are exposed to a wider range of per- and polyfluoroalkyl substances before birth than previously thought.

The FDA accepted a BLA for garetosmab for adults with fibrodysplasia ossificans progressiva, following positive phase 3 results in new bone formation.

Efgartigimod alfa–hyaluronidase significantly improves ocular symptoms in adults with ocular myasthenia gravis, according to phase 3 trial data.

Phase 3 trial results show combined ixekizumab and tirzepatide therapy outperforms ixekizumab alone for patients with psoriasis and obesity or overweight.

Pregnancy and breastfeeding are associated with stronger long-term cognitive ability among postmenopausal women.

A considerable proportion of pregnant women are colonized with enterobacterales with ampicillin and ceftriaxone resistance in the US.